Search results for: 'Microbiome Technologies Energizing Pharma and Life Sciences'

Microbiome science has become a key area of research for biopharmaceutical companies. At present, there are multiple start-ups emerging, which are focusing their resources towards the development of novel therapeutics as well as diagnostic/screening technologies and services. In an era of personalized medicine, the current trajectory of growth witn...

The microbiome sector is a core component of the self-care movement, promoting proactive health behaviors. The gut microbiota is now recognized as an organ-like system that influences overall health and specific medical conditions, making continued advancement critical to enhancing well-being.The consumer wellness industry is evolving alongside gro...

An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. Wi...

Frost & Sullivan s global IoT industry predictions for calendar 2024 are the result of aggregated input from Frost & Sullivan regional IoT and Edge research teams. Research analysts input leverages the extensive Frost & Sullivan knowledge base, as well as primary and secondary research. This Top 10 Growth Opportunities report reflects the hot ...

Owing to constant developments and challenges in the life sciences industry, stakeholders must continue to be adaptable, innovative, and competitive to thrive. Industry leaders must reconsider their strategic positions annually by understanding the main forces behind the transformation, including potential, challenges, and drivers. This analysis e...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

Laboratory information management systems (LIMS) have been used in life sciences since laboratories began digitizing sample tracking and data management in the 1970s. Modern LIMS solutions enhance efficiency by automating workflows, improving data accuracy, and enabling seamless integration and offer strong compliance, secure centralized data manag...

29 Apr 2016  |  Global  |  Market Research

Global Life Science Instrumentation Market, Forecast to 2020

Innovative Next-generation Sequencing (NGS) Technology to Fuel Growth

Infographics

×

The global life science instrumentation market recorded revenue of $4.05 billion in 2015; it is expected to grow at a Cumulative Annual Growth Rate (CAGR) of 7.6% from 2015 to 2020. Next-generation Sequencing (NGS) instruments has outpaced other research instruments due to reduced sequencing costs. Thermo Fisher Scientific, Agilent Technologies, an...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming AI-enabled discovery, precision diagnostics, cell engineering, targeted therapeutics, vaccines, and skin health across oncology, metabolic disease, rare disorders, neuropsychiatry, and ne...